Quantum Genomics Sa Stock Last Dividend Paid
ALQGC Stock | EUR 0.07 0 1.77% |
Quantum Genomics SA fundamentals help investors to digest information that contributes to Quantum Genomics' financial success or failures. It also enables traders to predict the movement of Quantum Stock. The fundamental analysis module provides a way to measure Quantum Genomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Quantum Genomics stock.
Quantum |
Quantum Genomics SA Company Last Dividend Paid Analysis
Quantum Genomics' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
Competition |
Based on the recorded statements, Quantum Genomics SA has a Last Dividend Paid of 0.0. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all France stocks average (which is currently at 0.0).
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
All Next | Launch Module |
Quantum Fundamentals
Return On Equity | -1.23 | |||
Return On Asset | -0.48 | |||
Operating Margin | (5.48) % | |||
Current Valuation | (11.33 M) | |||
Shares Outstanding | 34.53 M | |||
Shares Owned By Insiders | 9.18 % | |||
Shares Owned By Institutions | 3.69 % | |||
Price To Earning | (5.10) X | |||
Price To Book | 0.32 X | |||
Price To Sales | 1.07 X | |||
Revenue | 116.21 K | |||
Gross Profit | (12.47 M) | |||
EBITDA | (18.94 M) | |||
Net Income | (17.36 M) | |||
Cash And Equivalents | 5.01 M | |||
Cash Per Share | 0.89 X | |||
Total Debt | 283.69 K | |||
Current Ratio | 3.36 X | |||
Book Value Per Share | 0.44 X | |||
Cash Flow From Operations | (17.02 M) | |||
Earnings Per Share | (0.73) X | |||
Target Price | 8.8 | |||
Beta | 0.27 | |||
Market Capitalization | 5.65 M | |||
Total Asset | 22.59 M | |||
Z Score | 11.4 | |||
Net Asset | 22.59 M |
About Quantum Genomics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Quantum Genomics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Quantum Genomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Quantum Genomics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Quantum Stock Analysis
When running Quantum Genomics' price analysis, check to measure Quantum Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quantum Genomics is operating at the current time. Most of Quantum Genomics' value examination focuses on studying past and present price action to predict the probability of Quantum Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quantum Genomics' price. Additionally, you may evaluate how the addition of Quantum Genomics to your portfolios can decrease your overall portfolio volatility.